Skip to main content

Femoral Fracture

0
Pipeline Programs
5
Companies
7
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Stryker
StrykerCA - San Jose
3 programs
Femoral Nail GT of the T2 Alpha Femur Antegrade GT/PF Nailing SystemN/A1 trial
Femoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing SystemN/A1 trial
Gamma4 Nailing SystemN/A1 trial
Active Trials
NCT04015128Active Not Recruiting66Est. May 2026
NCT04015154Completed53Est. Sep 2025
NCT05523635Completed100Est. Oct 2025
Innovation Pharmaceuticals
1 program
Fracture MonitorN/A1 trial
Active Trials
NCT05410587Recruiting37Est. Jul 2026
Quanta Therapeutics
Quanta TherapeuticsCA - South SF
1 program
Implantation of Ortholoop cerclageN/A1 trial
Active Trials
NCT05087667Recruiting202Est. Dec 2028
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
The Role of Fat Emboli in the Trauma Inflammatory ResponseN/A1 trial
Active Trials
NCT02069327Completed9Est. Nov 2014
Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
ZNN Bactiguard Retrograde Femoral NailN/A1 trial
Active Trials
NCT05276674Recruiting100Est. Dec 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Zimmer BiometZNN Bactiguard Retrograde Femoral Nail
Innovation PharmaceuticalsFracture Monitor
StrykerGamma4 Nailing System
Quanta TherapeuticsImplantation of Ortholoop cerclage
StrykerFemoral Nail GT of the T2 Alpha Femur Antegrade GT/PF Nailing System
StrykerFemoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing System
Colorado TherapeuticsThe Role of Fat Emboli in the Trauma Inflammatory Response

Clinical Trials (7)

Total enrollment: 567 patients across 7 trials

NCT05276674Zimmer BiometZNN Bactiguard Retrograde Femoral Nail

ZNN Bactiguard Retrograde Femoral Nails PMCF Study

Start: Oct 2023Est. completion: Dec 2027100 patients
N/ARecruiting
NCT05410587Innovation PharmaceuticalsFracture Monitor

Fracture Monitor - Femur

Start: Oct 2023Est. completion: Jul 202637 patients
N/ARecruiting
NCT05523635StrykerGamma4 Nailing System

Post Market Clinical Evaluation of Gamma 4

Start: Mar 2023Est. completion: Oct 2025100 patients
N/ACompleted
NCT05087667Quanta TherapeuticsImplantation of Ortholoop cerclage

Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) )

Start: Mar 2022Est. completion: Dec 2028202 patients
N/ARecruiting
NCT04015128StrykerFemoral Nail GT of the T2 Alpha Femur Antegrade GT/PF Nailing System

A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT

Start: Sep 2019Est. completion: May 202666 patients
N/AActive Not Recruiting
NCT04015154StrykerFemoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing System

A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF

Start: Sep 2019Est. completion: Sep 202553 patients
N/ACompleted
NCT02069327Colorado TherapeuticsThe Role of Fat Emboli in the Trauma Inflammatory Response

The Role of Fat Emboli in the Trauma Inflammatory Response

Start: Nov 2012Est. completion: Nov 20149 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 actively recruiting trials targeting 567 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.